)

Alaunos Therapeutics (TCRT) investor relations material
Alaunos Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Focus shifted to preclinical small molecule obesity/metabolic disorder program, with ongoing in vitro and in vivo studies and initial data expected by Q4 2025.
Oncology TCR-T program wound down in 2023 due to high costs and challenging financing; workforce reduced by 95% and key licenses terminated.
Exploring strategic alternatives including M&A, asset sales, partnerships, and capital raises; Cantor Fitzgerald engaged as advisor.
No product revenue; only nominal royalty income; net losses continue and accumulated deficit reached $922.6 million as of June 30, 2025.
Financial highlights
Net loss of $1.05 million for Q2 2025, compared to $1.13 million in Q2 2024; net loss of $2.12 million for the six months ended June 30, 2025, versus $2.81 million in the prior year period.
Revenue for Q2 2025 was $0, down from $4,000 in Q2 2024; six-month revenue was $2,000, down from $6,000 year-over-year.
Research and development expenses increased 3% year-over-year for Q2 2025 and 74% for the six months, mainly due to obesity program consulting and regulatory costs.
General and administrative expenses decreased 14% for Q2 2025 and 39% for the six months, reflecting cost-cutting and downsized operations.
Cash and cash equivalents were $2.9 million as of June 30, 2025; working capital was $2.6 million.
Outlook and guidance
Cash resources expected to fund operations into Q1 2026; additional capital required to continue beyond that period.
Initial data from obesity program studies anticipated by Q4 2025; advancement to IND-enabling studies contingent on results and financing.
Actively seeking strategic transactions to maximize stockholder value; no assurance of successful outcome.
Next Alaunos Therapeutics earnings date

Next Alaunos Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage